
A pharmacy organization says all health-providers need to help prevent and fight antimicrobial resistance.
A pharmacy organization says all health-providers need to help prevent and fight antimicrobial resistance.
Medical cannabis classes will no longer be held at the University of Maryland-Baltimore.
Is Amazon getting in on the PBM game?
Sometimes the people on top make your life miserable.
A worldwide operation shuts down hundreds of illegal websites.
The chain’s PBM will limit opioid prescriptions, along with a host of other opioid safety programs.
FDA issues new communication about risk of liver injury with Ocaliva (obeticholic acid).
A new communication says benzodiazepines can be used with buprenorphine or methadone, if carefully managed.
New data show that health benefit costs in 2018 will rise by their highest since 2011.
The pharmacy is launching its #ItEndsWithUs campaign to educate teens.
The pharmacy faces sanctions after nearly 1,000 IV bags were made with expired ingredients.
Gottlieb says that changes may be coming, but remains firm on current regulations.
A California bill aimed at curbing drug prices is about to be signed, despite concerns it will raise generic drug prices.
CVS Health executives are pleased that a lawsuit alleging collusion with PBMS on generic drug costs has been withdrawn.
After the failed merger, Walgreens gets go-ahead to purchase hundreds of Rite Aid stores.
Adverse events after vaccinations don’t usually recur after reimmunizations.
First dose of HepB vaccine should be given in the first 24 hours to prevent infection.
A huge number of opioids go unused. So where do they go?
Rite Aid’s KidsCents will offer free flu shots to children.
Hospital pharmacists and physicians saved millions on cardiovascular meds.
The new machines will feature of variety of OTC meds and other products.
International pharmacy group says that pharmacists should create advance plans for major disasters.
In Clinical Challenge, we give you one case and two different expert opinions. You decide the best approach.
Nonadherence to treatment plans is a contributing factor in for many second myocardial infarctions.
PBMs are evolving, but what will they be evolving into and will they be more transparent?
Neratinib (Nerlynx) is an extended adjuvant treatment for patients with early stage HER2 positive breast cancer who are receiving trastuzumab therapy.
Opioid limits are gaining popularity, but do they actually work?
Technology can help reduce error rates in IV compounding.
Ransomware and cybersecurity threats expose patients to risks.
It's no news that pharmacists are stressed, but how is it affecting job performance-and how do pharmacists cope?